0001214659-18-007681.txt : 20181213 0001214659-18-007681.hdr.sgml : 20181213 20181213185732 ACCESSION NUMBER: 0001214659-18-007681 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181206 FILED AS OF DATE: 20181213 DATE AS OF CHANGE: 20181213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martinez Maria E CENTRAL INDEX KEY: 0001761768 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 181234281 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-43510.xml PRIMARY DOCUMENT X0306 4 2018-12-06 0001576263 Mirati Therapeutics, Inc. MRTX 0001761768 Martinez Maria E C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 true false false false Non Qualified Stock Option (right to buy) 39.76 2018-12-06 4 A false 25000 0 A 2028-12-05 Common Stock 25000 25000 D The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant. /s/ Vickie Reed, Attorney-in-Fact 2018-12-13